Page last updated: 2024-08-23

ursodeoxycholic acid and Cholangitis

ursodeoxycholic acid has been researched along with Cholangitis in 158 studies

Research

Studies (158)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (1.90)	18.7374
1990's	14 (8.86)	18.2507
2000's	14 (8.86)	29.6817
2010's	80 (50.63)	24.3611
2020's	47 (29.75)	2.80

Authors

Authors	Studies
Amaral-González, C; Chico, I; Díaz-Flores, F; Eirás, P; Hernández-Guerra de Aguilar, MN; Hernández-Pérez, M; Llorente, S; Molina-Pérez, E; Morales-Arráez, D; Olveira-Martín, A; Rodríguez, R; Spigarelli-de Rábago, I; Suárez-Cabredo, C; Suárez-Ferrer, C; Tejedor, M; Yebra-Carmona, J	1
Parés, A	2
Chen, Q; Dong, K; Jin, Q; Kui, Y; Ma, B; Wang, Y; Wen, X; Zhong, R	1
Alrubaiy, L; Lambert, JA; Mak, S; Patel, R; Portone, G	1
Abe, M; Alvaro, D; Bernasconi, DP; Carbone, M; Cazzagon, N; Corpechot, C; Cristoferi, L; Floreani, A; Gerussi, A; Hansen, BE; Hirschfield, G; Inao, M; Invernizzi, P; Komori, A; Lindor, K; Marzioni, M; Mochida, S; Muselli, M; Namisaki, T; Pares, A; Tanaka, A; Valsecchi, MG; Verda, D; Vespasiani-Gentilucci, U; Yoshiji, H	1
Barreyro, FJ; Daruich, J; González Ballerga, E; Sorda, JA	1
Banales, JM; Rodrigues, PM	1
Chazouillères, O; Corpechot, C; Soret, PA	1
Mayo, MJ	1
Abrahamyan, L; Aziz, B; Cheung, A; Flemming, JA; Grbic, D; Gulamhusein, AF; Hansen, BE; Hirschfield, GM; Janssen, HLA; Ko, HH; Lytvyak, E; Mason, AL; Montano-Loza, AJ; Peltekian, K; Qumosani, K; Roberts, SB; Selzner, N; Swain, M; Tirona, K; Vincent, C; Worobetz, LJ	1
Mishra, AK; Singh, SP	1
Abbas, N; Aspinall, R; Chimakurthi, CR; Crothers, H; Culver, EL; Dyson, JK; Halliday, N; Hegade, V; Hirschfield, G; Jones, D; Jones, R; Kallis, Y; Khakoo, SI; McCune, A; Mells, G; Orrell, M; Patanwala, I; Phaw, A; Smith, B; Thain, C; Thain, RM; Thorburn, D; Trivedi, PJ	1
Liu, BD; Qureshi, K	1
Díaz-González, Á; Londoño, MC	1
John, BV; Mansour, N; Shaker, M	1
Ferreira, RD; John, BV; Sy, AM	1
Bowlus, CL; Liu, CH	1
Buchanan-Peart, KA; Levy, C	1
John, BV	1
Feng, Y; Li, S; Xie, B; Zhang, H; Zhang, Q	1
Carbone, M; Drazilova, S; Gazda, J; Gazda, M; Janicko, M; Jarcuska, P; Koky, T; Macej, M	1
Gershwin, ME; Han, Y; Leung, PSC; Shang, Y	1
Bowlus, CL; Kowdley, KV; Levy, C; Mayo, MJ; Pratt, DS; Vuppalanchi, R; Younossi, ZM	1
Hirschfield, G; Levy, C; Manns, M	1
Kim, KA	1
Barba Bernal, R; Bonder, A; Castro, CM; Ferrigno, B; Goyes, D; Medina Morales, E; Patwardhan, VR; Trivedi, H	1
Bogdanos, DP; Rigopoulou, EI	1
Chen, Y; Lin, L	1
Choi, HY; Jang, ES; Jeong, SH; Ki, M; Kim, KA	1
John, BV; Levy, C; Trivella, J	1
Gao, L; He, X; Leung, PSC; Rojas, M; Yang, Y	1
Hou, C; Li, S; Luan, L; Ren, C	1
Bassi, M; Muzahim, Y; Pyrsopoulos, N; Wakil, A	1
Faisal, MS; Gonzalez, HC; Gordon, SC	1
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, G; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Lygoura, V; Mason, AL; Mayo, MJ; Nevens, F; Pares, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; Verhelst, X; Zachou, K	1
Chazouillères, O; Corpechot, C	1
Efe, C; Montano-Loza, AJ; Taşçilar, K; Wahlin, S; Yoshida, EM	1
Bowlus, CL; Levy, C	1
Schattenberg, JM	1
Battezzati, PM; Bruns, T; Carbone, M; Corpechot, C; Dalekos, GN; Feld, JJ; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van Buuren, HR; van der Meer, AJ; Verhelst, X	1
Carbone, M; Gerussi, A; Invernizzi, P; Mulinacci, G; Palermo, A	1
Cerny, A; Costantini, S; Di Bartolomeo, C; Kolbus, N; Mazzucchelli, L; Merlo, E; Mertens, J; Messina, P; Mieli-Vergani, G; Semela, D; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D; Voreck, A; Zen, Y	1
Gershwin, ME; Hirschfield, GM; Lleo, A; Wang, GQ	1
Bloks, VW; de Boer, JF; de Vries, HD; Doestzada, M; Dombrowicz, D; Fu, J; Haas, JT; Hoogerland, JA; Hovingh, MV; Kloosterhuis, NJ; Koehorst, M; Kuipers, F; La Rose, AM; Li, R; Mulder, NL; Palmiotti, A; Staels, B; van de Sluis, B; Westerterp, M; Wolters, JC	1
Fan, X; Huang, C; Liu, Y; Shen, M; Xiang, X; Yang, L; Yang, X	1
Usami, J	1
He, D; Hübscher, SG; Lytvyak, E; Mason, AL; Niazi, M; Pai, R; Zhang, G	1
Corpechot, C	1
Dyson, JK; Jones, DEJ; Wetten, A	1
Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E	1
Jones, DE; Mells, GF	1
Hegade, VS; Jones, DEJ; Wong, LL	1
Choi, G; Jimenez, M; Rahal, H; Saab, S; Suraweera, D; Viramontes, M	1
Alvaro, D; Canonico, PL; Carbone, M; Craxi, A; Floreani, A; Gardini, I; Gasbarrini, A; Invernizzi, P; Kruger, P; Lanati, E; Marzioni, M; Mennini, FS; Muratori, L; Ronco, V; Vespasiani Gentilucci, U	1
Lemoinne, S; Marteau, P	1
Bacon, BR; Bernstein, DE; Boudes, PF; Bowlus, CL; Buggisch, P; Chera, H; Choi, YJ; Clark, V; Corless, L; Doerffel, Y; Freilich, BL; Galambos, MR; Gitlin, N; Gordon, SC; Hartleb, M; Hartmann, H; Hirschfield, GM; Janczewska, E; Jonas, ME; Jones, D; Kremer, AE; Levy, C; Martin, R; McWherter, CA; Mells, GF; Odin, JA; Rochling, F; Shah, H; Sheridan, D; Shiffman, ML; Smith, JH; Steinberg, A; Swain, MG; Varga, M; Vierling, JM; Wörns, MA	1
Lindor, KD; Silveira, MG	1
Burman, BE; Jhaveri, MA; Kowdley, KV	1
Bernuzzi, F; Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V	1
Anaya, JM; Gershwin, ME; Lleo, A; Marzorati, S	1
Baserga, A; Bihl, F; Carbone, M; Cerny, A; Filipowicz Sinnreich, M; Giostra, E; Helbling, B; Hessler, R; Invernizzi, P; Kalid-de Bakker, C; Mertens, J; Oneta, C; Semela, D; Stickel, F; Stirnimann, G; Terziroli Beretta-Piccoli, B	1
Levy, C	1
Honda, H; Kamimura, H; Kimura, N; Setsu, T; Takamura, M; Terai, S; Tominaga, K; Tsuchiya, A; Yamagiwa, S	1
Al Ani, M; Nadir, A; Quigley, G	1
Jansen, PLM	1
Levy, C; Lindor, KD	1
Dixon, P; Ferraro, E; Gorelik, J; Ibrahim, E; Vasavan, T; Williamson, C	1
Duan, WJ; Jia, JD	1
Li, YM; Ma, X; Wang, QX	1
Bossen, L; Grønbæk, H; Hamberg, O; Jepsen, P; Ott, P; Ytting, H	1
Alexander, GJM; Chapman, MH; Collier, J; Dyson, JK; Hirschfield, GM; Hübscher, S; Jones, DEJ; Patanwala, I; Pereira, SP; Thain, C; Thorburn, D; Tiniakos, D; Walmsley, M; Webster, G	1
Almishri, W; Frolkis, AD; Kaplan, GG; Patten, S; Shaheen, AA; Swain, MG; Vallerand, I	1
Kremer, AE; Vetter, M	1
Duan, W; Jia, J; Ma, H; Ou, X; Wang, Q; Wang, X; Wang, Y; Wu, X; You, H; Zhang, W; Zhao, X	1
Gonzalez, RS; Washington, K	1
Abergel, A; Admane, FH; Boursier, J; Bronowicki, JP; Chazouillères, O; Chollet-Martin, S; Corpechot, C; de Chaisemartin, L; de Ledinghen, V; Debette-Gratien, M; Gaouar, F; Goria, O; Habersetzer, F; Heurgue-Berlot, A; Humbert, L; Larrey, D; Le Gruyer, A; Lefèvre, G; Lemoinne, S; Mathurin, P; Minello, A; Nguyen-Khac, E; Nkontchou, G; Ollivier-Hourmand, I; Potier, P; Poupon, R; Rainteau, D; Rousseau, A; Roux, O; Silvain, C; Simon, T; Zarski, JP; Zoulim, F	1
Christ, MM	1
Marschall, HU	1
Lenzi, M; Muratori, L; Muratori, P	1
Aubert, V; Fraga Christinet, M; Moradpour, D; Sciarra, A; Sempoux, C; Vieira Barbosa, J; Vionnet, J	1
Hegade, VS; Jones, DE	1
Korula, J	1
Aguilera, L; Albillos, A; Martínez, J	1
Klose, G; Nitschmann, S	1
Kim, BH	1
Alexander, GJ; DiBello, J; Fisher, H; Gilchrist, K; Hegade, VS; Hirschfield, GM; Jones, DEJ; Kendrick, S; Mells, GF; Sandford, RN	1
Abu Backer, F; Abu Mouch, S; Mari, A	1
Chazouillères, O; Corpechot, C; Lemoinne, S; Rousseau, A	1
Battezzati, PM; Bruns, T; Carbone, M; Cheung, AC; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lazaridis, KN; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Poupon, R; Thorburn, D; Trivedi, PJ; van Buuren, HR; Verhelst, X	1
Han, Y; Jia, G; Yuan, Z	1
Abe, M; Arakawa, M; Fujii, H; Hashimoto, N; Honda, A; Iimuro, S; Inao, M; Itakura, J; Joshita, S; Kakisaka, K; Kaneko, A; Kaneko, T; Kang, JH; Kawada, N; Kawata, K; Kikuchi, K; Komori, A; Masaki, T; Matsuzaki, Y; Mochida, S; Namisaki, T; Ninomiya, M; Nomura, T; Ohira, H; Sato, K; Takahashi, A; Takikawa, H; Takikawa, Y; Tanaka, A; Umemura, T; Yamagiwa, S; Yoshiji, H	1
Bancel, B; Brunel, T; Goubault, P; Mabrut, JY; Mohkam, K; Rode, A	1
Andreone, P; Bowlus, CL; Drenth, JPH; Hirschfield, GM; MacConell, L; Malecha, ES; Nevens, F; Pencek, R; Shapiro, D; Shiffman, ML; Trauner, M; Vargas, V	1
Battezzati, PM; Corpechot, C; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; van der Meer, AJ	1
D'Adda, A; D'Antiga, L; Di Giorgio, A; Licini, L; Marseglia, A; Nicastro, E; Sonzogni, A	1
Descourt, R; Fouchard, M; Jantzem, H; Poureau, PG; Quere, G; Robinet, G	1
Harada, K; Kakuda, Y; Nakamura, M; Nakanuma, Y; Shimoda, S	1
Favier, RP; Otte, CM; Penning, LC; Rothuizen, J; Vreman, S	1
Carpenter, NA; Crook, EK	1
Akiyama, S; Imamura, T; Koizumi, Y; Koyama, R; Takeuchi, K; Tamura, T; Watanabe, G	1
Adgey, C; Aldersley, M; Alexander, GJ; Bathgate, A; Burroughs, AK; Carbone, M; Cordell, HJ; Flack, S; Griffiths, L; Heneghan, MA; Hirschfield, GM; Jones, DE; Lim, R; Mells, GF; Neuberger, JM; Paximadas, D; Sandford, RN; Sharp, SJ; Spiess, K; Thorburn, D; Trembling, P; Wareham, NJ; Williamson, K	1
Stiefelhagen, P	1
Dong, SH; Oh, CH	1
Dasgupta, B; Gershwin, ME; Hirschfield, GM; Johanns, J; Jones, D; Levy, C; Li, K; Lindor, K; Marschall, HU; Mayo, MJ; Nnane, IP; Selmi, C; Strauss, R; Zou, B	1
Eksteen, B	1
Ali, AH; Carey, EJ; Lindor, KD; Tabibian, JH	1
Bruno, S; Carbone, M; Invernizzi, P; Mells, GF; Ronca, V	1
Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V	1
Dong, Y; Gao, ZH; Han, YX; Huang, CY; Li, HM; Li, N; Li, ZM; Tan, YG; Wang, XF; Wang, YQ; Wu, XL; Yan, HP; Zhang, HP; Zhang, M; Zhu, HM; Zhu, SD	1
Ali, AH; Lindor, KD	1
Daa, T; Kan, M; Omori, K; Yokota, M; Yoshida, K	1
He, X; Hou, J; Li, Y; Liu, J; Tang, L; Wang, W; Zhong, R; Zhu, Y	1
Harinck, F	1
Bowlus, CL; Kenney, JT; Navarro, R; Rice, G	1
Erlinger, S	1
Chen, C; Chen, G; Chen, M; Cheng, L; Duan, L; Fu, X; Gao, Z; Han, Y; Hu, H; Jia, J; Ma, H; Miao, X; Ning, Q; Sheng, J; Shi, G; Tang, H; Wang, G; Wang, J; Wei, L; Wu, S; Xie, Q; Xie, W; Xu, J; Yan, H; Yao, C; Zeng, M; Zhu, Y	1
Ansari, A; Cao, Q; Chen, H; Chen, W; Fan, Z; Fang, JY; Gershwin, ME; Jiang, X; Li, Y; Lian, M; Ma, X; Miao, Q; Qiu, D; Tang, R; Wang, Q; Wei, Y; Wu, M; Xiao, X; Yang, F; Zhang, H; Zhang, J	1
Bonder, A; Lizaola, B; Tapper, EB; Trivedi, HD	1
Joshita, S; Ota, M; Tanaka, E; Umemura, T	1
Chatzimavroudis, G; Katsinelos, P; Kountouras, J; Paroutoglou, G; Pilpilidis, I; Zavos, C	1
Jüngst, D	1
Dia, D; Ka, MM; Mbengue, M; Moreira Diop, T; Ndongo, S; Seck, SM	1
Alvaro, D; Attili, AF; Bragazzi, MC; Callea, F; Giubilo, F; Merli, M	1
Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R	1
Fujino, Y; Kanemoto, H; Karasawa, A; Nakashima, K; Ohno, K; Osumi, T; Tsujimoto, H; Uchida, K	1
Fabris, L; Fiorotto, R; Hoque, R; Scirpo, R; Spirli, C; Strazzabosco, M; Trauner, M	1
Akcam, M; Büyükyavuz, BI; Duman, L; Koroglu, M; Tepeli, H	1
Favier, RP; Otte, CM; Penning, LC; Rothuizen, J	1
Gisbert, JP; Jones, EA; Moreno-Otero, R; Pajares, JM	1
Blum, HE; Kreisel, W; Opitz, OG; Thimme, R	1
Kiss, E; Mayer, S; Rogler, G; Schedel, J; Schölmerich, J; Woenckhaus, M	1
Angulo, P; Lindor, KD	1
Barbati, K; Karachalios, G; Karachaliou, I; Kostakos, N; Papamichael, K; Petrogiannopoulos, C; Zacharof, A	1
Ananthakrishnan, AN; Saeian, K	1
Pan, MH; Zhou, XJ	1
Hofstetter, JR	1
Schentke, KU	1
Ghory, MJ; Hunter, GC; Rappaport, W; Shen, GK; Tsen, AC	1
Montet, JC; Queneau, PE	1
Dingemans, KP; Elferink, RP; Groen, AK; Offerhaus, GJ; Ottenhoff, R; Tytgat, GN; Van Den Bergh Weerman, MA; Van Nieuwkerk, CM	1
Bianchi, L; Dienes, HP; Gerken, G; Helmreich-Becker, I; Lohse, AW; Meyer zum Büschenfelde, KH; Protzer, U	1
Canga, F; Castellano, G; Colina, F; Dominguez, P; Herruzo, JA; Rodriguez, S; Sánchez-Pobre, P	1
Feeney, SJ; Hara, K; Ikuno, N; Mackay, IR; Matsuo, I; Omagari, K; Shirono, K; Whittingham, S	1
Higuchi, K; Kashii, Y; Miyamoto, M; Shimizu, Y; Tsukishiro, T; Watanabe, A	1
Bruguera, M; Caballería, L; Parés, A; Rodés, J; Saló, J	1
Fiedler, GM; Grunewald, RW; Müller, GA; Schauer, A; Stöckmann, F	1
Armengol-Miro, JR; Buckley, MJ; Caroli-Bosc, FX; Conio, M; Delmont, JP; Demarquay, JF; Dumas, R; Paolini, O; Peten, EP	1
Häussinger, D; Heintges, T; Hensel, F; Mohr, L; Niederau, C	1
Bordas, JM; Evia, A; Ginès, A; Llach, J; Mondelo, F	1
Chang, FY; Co, RL; Hwang, SJ; Lee, SD; Li, CP; Luo, JC; Tong, MJ; Tsay, SH	1
Carpenter, HA; Czaja, AJ; Moore, SB; Santrach, PJ	1
Adachi, Y; Kimura, M; Kobayashi, Y; Koshiyama, H; Makita, Y; Nakao, K; Tanaka, Y; Yoshida, Y	1
Alvarez, V; Castellano, G; Colina, F; Gonzalez, C; Muñoz-Yague, T; Paz, E; Rodriguez, S; Sánchez-Pobre, P; Solís-Herruzo, J; Yela, C	1
Malè, PJ; Meyer, P	1

Reviews

46 review(s) available for ursodeoxycholic acid and Cholangitis

Article	Year
Disease-modifying therapies and symptomatic management for primary biliary cholangitis. British journal of hospital medicine (London, England : 2005), 2021, Nov-02, Volume: 82, Issue:11 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2021
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis? Hepatology (Baltimore, Md.), 2022, Volume: 76, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Fibrosis; Humans; Inflammation; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Prognosis; Ursodeoxycholic Acid	2022
Hepatocellular Carcinoma in Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Ursodeoxycholic Acid	2022
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Autoimmune Diseases; Bezafibrate; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Novel Therapies in Primary Biliary Cholangitis: What Is in the Pipeline? Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2022
Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis. Clinical and experimental medicine, 2023, Volume: 23, Issue:5 Topics: Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Treatment Outcome; Ursodeoxycholic Acid	2023
Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:10 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2023
New Treatment Paradigms in Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:8 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Peroxisome Proliferator-Activated Receptors; Pruritus; Quality of Life; Ursodeoxycholic Acid	2023
[Diagnosis and Treatment of Primary Biliary Cholangitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2023, 02-25, Volume: 81, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2023
Role of autoantibodies in the clinical management of primary biliary cholangitis. World journal of gastroenterology, 2023, Mar-28, Volume: 29, Issue:12 Topics: Antibodies, Antinuclear; Autoantibodies; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Frontiers in immunology, 2023, Volume: 14 Topics: Animals; Cholangitis; Cholestasis; Fibrosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Treatment of Primary Biliary Cholangitis including Transplantation. Clinics in liver disease, 2024, Volume: 28, Issue:1 Topics: Cholagogues and Choleretics; Cholangitis; Female; Fibric Acids; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2024
Primary Biliary Cholangitis: Epidemiology, Diagnosis, and Presentation. Clinics in liver disease, 2024, Volume: 28, Issue:1 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2024
Primary biliary cholangitis. Lancet (London, England), 2020, 12-12, Volume: 396, Issue:10266 Topics: Autoimmune Diseases; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fatigue; Humans; Pruritus; Risk Factors; Ursodeoxycholic Acid	2020
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. The Cochrane database of systematic reviews, 2017, 03-28, Volume: 3 Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis? Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2017
Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:12 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Colchicine; Fibric Acids; Humans; Immunosuppressive Agents; Silymarin; Treatment Failure; Ursodeoxycholic Acid	2017
Investigational drugs in phase II clinical trials for primary biliary cholangitis. Expert opinion on investigational drugs, 2017, Volume: 26, Issue:10 Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Drug Design; Drugs, Investigational; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis. Clinics in liver disease, 2017, Volume: 21, Issue:4 Topics: Aftercare; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Disease Management; Disease Progression; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2017
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis. Expert review of clinical immunology, 2017, Volume: 13, Issue:12 Topics: Autoimmunity; Bile Ducts, Intrahepatic; Chenodeoxycholic Acid; Cholangitis; Fibrosis; Humans; Immunotherapy; Liver; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid; Ustekinumab	2017
Primary biliary cholangitis: a comprehensive overview. Hepatology international, 2017, Volume: 11, Issue:6 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Biopsy; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Immunosuppressive Agents; Liver; Prognosis; Ursodeoxycholic Acid	2017
New therapies target the toxic consequences of cholestatic liver disease. Expert review of gastroenterology & hepatology, 2018, Volume: 12, Issue:3 Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Chronic Disease; Humans; Organic Anion Transporters, Sodium-Dependent; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Symporters; Ursodeoxycholic Acid	2018
Heart and bile acids - Clinical consequences of altered bile acid metabolism. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:4 Pt B Topics: Apoptosis; Arrhythmias, Cardiac; Bile Acids and Salts; Cardiomyopathies; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Female; Heart; Hemodynamics; Humans; Hydrophobic and Hydrophilic Interactions; Liver Cirrhosis, Biliary; Maternal-Fetal Exchange; Myocytes, Cardiac; Pregnancy; Pregnancy Complications; Prevalence; Ursodeoxycholic Acid	2018
[New name and new treatments for primary biliary cholangitits]. Ugeskrift for laeger, 2018, Mar-05, Volume: 180, Issue:10 Topics: Anti-Inflammatory Agents; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2018
[Primary biliary cholangitis-established and novel therapies]. Der Internist, 2018, Volume: 59, Issue:6 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Pruritus; Quality of Life; Ursodeoxycholic Acid	2018
Primary Biliary Cholangitis and Autoimmune Hepatitis. Surgical pathology clinics, 2018, Volume: 11, Issue:2 Topics: Biopsy; Cholangitis; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Prognosis; Ursodeoxycholic Acid	2018
Risk stratification and treatment of primary biliary cholangitis. Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:1 Topics: Adult; Age Factors; Alkaline Phosphatase; Biomarkers; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Fibric Acids; Glucocorticoids; Humans; Liver Cirrhosis; Liver Transplantation; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure; Ursodeoxycholic Acid	2019
[PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA]. Harefuah, 2018, Volume: 157, Issue:12 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Quality of Life; Ursodeoxycholic Acid	2018
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review. Journal of visceral surgery, 2019, Volume: 156, Issue:4 Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B; Bile; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis; Cholangitis, Sclerosing; Cholecystectomy; Cholelithiasis; Codon, Nonsense; Diagnosis, Differential; Female; Gallstones; Humans; Lithiasis; Liver Abscess; Liver Cirrhosis, Biliary; Liver Diseases; Mutation; Phosphatidylcholines; Pregnancy; Pregnancy Complications; Recurrence; Syndrome; Ultrasonography; Ursodeoxycholic Acid	2019
[Recent Advances in the Management of Recurrent Bile Duct Stones]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2015, Volume: 66, Issue:5 Topics: Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Gallstones; Humans; Recurrence; Risk Factors; Sphincterotomy, Endoscopic; Ursodeoxycholic Acid	2015
Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert opinion on emerging drugs, 2016, Volume: 21, Issue:1 Topics: Alkaline Phosphatase; Animals; Autoantibodies; Cholangitis; Chronic Disease; Disease Progression; Drug Design; Female; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Male; Mitochondria; Ursodeoxycholic Acid	2016
Toward precision medicine in primary biliary cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:8 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis; Clinical Trials as Topic; Disease Progression; Elasticity Imaging Techniques; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Precision Medicine; Ursodeoxycholic Acid	2016
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach. Autoimmunity reviews, 2016, Volume: 15, Issue:9 Topics: Animals; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Disease Progression; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2016
Obeticholic acid for the treatment of primary biliary cholangitis. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13 Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2016
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update. Journal of managed care & specialty pharmacy, 2016, Volume: 22, Issue:10-a-s Sup Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Congresses as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Education, Pharmacy, Continuing; End Stage Liver Disease; Evidence-Based Medicine; Formularies as Topic; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Liver Transplantation; Middle Aged; Prescription Fees; Rare Diseases; Receptors, Cytoplasmic and Nuclear; Satellite Communications; Ursodeoxycholic Acid	2016
Novel Treatment Strategies for Primary Biliary Cholangitis. Seminars in liver disease, 2017, Volume: 37, Issue:1 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Fibric Acids; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review. The American journal of medicine, 2017, Volume: 130, Issue:6 Topics: Cholagogues and Choleretics; Cholangitis; Depression; Fatigue; Humans; Pruritus; Quality of Life; Sleep Wake Disorders; Suicidal Ideation; Ursodeoxycholic Acid	2017
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis. Journal of immunology research, 2017, Volume: 2017 Topics: Alleles; Cholangitis; Disease Susceptibility; Genetic Predisposition to Disease; Genome-Wide Association Study; HLA Antigens; Humans; Liver Cirrhosis, Biliary; Polymorphism, Genetic; Ursodeoxycholic Acid	2017
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:1 Topics: Antibodies; Cholangitis; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mitochondria, Liver; Treatment Outcome; Ursodeoxycholic Acid	2003
[Cholestatic liver diseases]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid	2004
Management of primary biliary cirrhosis and autoimmune cholangitis. Clinics in liver disease, 1998, Volume: 2, Issue:2 Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Cholangitis; Colchicine; Disease Progression; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Penicillamine; Ursodeoxycholic Acid	1998
Caroli's disease: identification and treatment strategy. Current gastroenterology reports, 2007, Volume: 9, Issue:2 Topics: Caroli Disease; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis; Humans; Hypertension, Portal; Liver Transplantation; Ursodeoxycholic Acid	2007
[Pathologic diagnosis of autoimmune liver disease]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:11 Topics: Autoimmune Diseases; Cholangitis; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Interferon-gamma; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2007
Hepatoprotection by hydrophilic bile salts. Journal of hepatology, 1994, Volume: 21, Issue:2 Topics: Bile Acids and Salts; Cholangitis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1994
Treatment of autoimmune cholangitis. Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; Humans; Immunosuppressive Agents; Middle Aged; Ursodeoxycholic Acid	1998

Trials

7 trial(s) available for ursodeoxycholic acid and Cholangitis

Article	Year
Ursodeoxycholic Acid at 18-22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis. Canadian journal of gastroenterology & hepatology, 2021, Volume: 2021 Topics: Cholagogues and Choleretics; Cholangitis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2021
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:10 Topics: Acetates; Adult; Aged; Alanine Transaminase; Cholangitis; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Liver; Male; Middle Aged; Nausea; PPAR delta; Pruritus; Treatment Outcome; Triazoles; Ursodeoxycholic Acid	2017
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. Clinical reviews in allergy & immunology, 2018, Volume: 54, Issue:2 Topics: Cholangitis; Cohort Studies; Cross-Sectional Studies; Delayed Diagnosis; Drug Resistance; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Switzerland; Treatment Outcome; Ursodeoxycholic Acid	2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. The New England journal of medicine, 2018, Jun-07, Volume: 378, Issue:23 Topics: Adult; Bezafibrate; Bile Acids and Salts; Cholangitis; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Treatment Failure; Ursodeoxycholic Acid	2018
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:6 Topics: Alkaline Phosphatase; Bilirubin; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid	2019
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study. Hepatology (Baltimore, Md.), 2016, Volume: 64, Issue:1 Topics: Adult; Aged; Biomarkers; Cholangitis; Female; Humans; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid; Ustekinumab	2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine, 2016, Volume: 95, Issue:47 Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; China; Cholagogues and Choleretics; Cholangitis; Double-Blind Method; Female; Humans; Male; Middle Aged; Taurochenodeoxycholic Acid; Treatment Outcome; Ursodeoxycholic Acid	2016

Other Studies

105 other study(ies) available for ursodeoxycholic acid and Cholangitis

Article	Year
Retrieval and treatment of patients with primary biliary cholangitis who are lost in the health system. Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:11 Topics: Aged; Alkaline Phosphatase; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Practical management of primary biliary cholangitis. Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:7 Topics: Adult; Cholangitis; End Stage Liver Disease; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Quality of Life; Ursodeoxycholic Acid	2022
The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:8 Topics: Antibodies; Cholangitis; Humans; Liver Cirrhosis, Biliary; Prognosis; Retrospective Studies; Ursodeoxycholic Acid	2022
Machine learning in primary biliary cholangitis: A novel approach for risk stratification. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:3 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Machine Learning; Prognosis; Risk Assessment; Ursodeoxycholic Acid	2022
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:2 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:2 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
[Primary biliary cholangitis]. La Revue du praticien, 2021, Volume: 71, Issue:8 Topics: Autoimmune Diseases; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2021
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology (Baltimore, Md.), 2022, Volume: 76, Issue:2 Topics: Canada; Carcinoma, Hepatocellular; Cholangitis; Ethnicity; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Quality of Life; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2022
Seladelpar in patients with primary biliary cholangitis: Need for a closer look! Journal of hepatology, 2022, Volume: 77, Issue:5 Topics: Acetates; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:6 Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC. Digestive diseases and sciences, 2023, Volume: 68, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:11 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
The Evolving Landscape of Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Primary biliary cholangitis: personalized medicine for optimal therapeutic opportunities. Science bulletin, 2022, 12-31, Volume: 67, Issue:24 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Precision Medicine; Ursodeoxycholic Acid	2022
Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis. The American journal of gastroenterology, 2023, 02-01, Volume: 118, Issue:2 Topics: Cholangitis; Cholestasis; Evidence-Based Medicine; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023, Volume: 34, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2023
[Interpretation of key points of the technical guidelines for clinical trials of drugs for the treatment of primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, Mar-20, Volume: 31, Issue:3 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Pharmaceutical Preparations; Ursodeoxycholic Acid	2023
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019. Journal of gastroenterology, 2023, Volume: 58, Issue:7 Topics: Aged; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Male; Republic of Korea; State Medicine; Ursodeoxycholic Acid	2023
Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatology communications, 2023, 06-01, Volume: 7, Issue:6 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Prognosis; Ursodeoxycholic Acid	2023
A case report of primary biliary cholangitis combined with ankylosing spondylitis. Medicine, 2023, Oct-13, Volume: 102, Issue:41 Topics: Antirheumatic Agents; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Spondylitis, Ankylosing; Ursodeoxycholic Acid	2023
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:3 Topics: Alanine Transaminase; Bilirubin; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2020
A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis. The American journal of gastroenterology, 2019, Volume: 114, Issue:10 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Risk Factors; Ursodeoxycholic Acid	2019
Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouillères. The American journal of gastroenterology, 2019, Volume: 114, Issue:10 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2019
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit. Gut, 2020, Volume: 69, Issue:8 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. The American journal of gastroenterology, 2020, Volume: 115, Issue:7 Topics: Alkaline Phosphatase; Bilirubin; Biomarkers; Cholagogues and Choleretics; Cholangitis; Female; Humans; Male; Middle Aged; Prognosis; Reference Values; Survival Rate; Ursodeoxycholic Acid	2020
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All. Digestive diseases and sciences, 2021, Volume: 66, Issue:5 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Racial Groups; Ursodeoxycholic Acid	2021
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. Journal of autoimmunity, 2021, Volume: 116 Topics: Adult; Aged; Alkaline Phosphatase; Autoantibodies; Cholangitis; Cohort Studies; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Practice Guidelines as Topic; Prognosis; Treatment Outcome; Ursodeoxycholic Acid	2021
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid. Cellular and molecular gastroenterology and hepatology, 2021, Volume: 11, Issue:4 Topics: Animals; Bile Acids and Salts; Biliary Tract Diseases; Cholangitis; Cholic Acids; Cytochrome P-450 Enzyme System; Female; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ursodeoxycholic Acid	2021
Primary Biliary Cholangitis-associated Palmar Keratosis. Internal medicine (Tokyo, Japan), 2021, Sep-01, Volume: 60, Issue:17 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Keratosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation. Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:8 Topics: Anti-Retroviral Agents; Cholangitis; HIV Infections; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2021
Reply to: "Chronic fatigue should not be overlooked in primary biliary cholangitis". Journal of hepatology, 2021, Volume: 75, Issue:3 Topics: Cholangitis; Fatigue Syndrome, Chronic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough? Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:15 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Pharmaceutical Preparations; Ursodeoxycholic Acid	2021
Stratified medicine and primary biliary cholangitis. The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:5 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Drug Therapy, Combination; Humans; Treatment Outcome; Ursodeoxycholic Acid	2017
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. Journal of hepatology, 2017, Volume: 67, Issue:1 Topics: Cholangitis; Female; Humans; Liver Transplantation; Male; Practice Guidelines as Topic; Prognosis; Ursodeoxycholic Acid	2017
Primary Biliary Cholangitis: advances in management and treatment of the disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:8 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Ursodeoxycholic Acid	2017
Gut microbial profile in primary biliary cholangitis: Towards bioindicators. Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:5 Topics: Cholangitis; Cholangitis, Sclerosing; Environmental Biomarkers; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Evolving role of obeticholic acid in primary biliary cholangitis. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:5 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cholangitis; Cytokines; Female; Humans; Liver; Male; Middle Aged; Mucosal-Associated Invariant T Cells; Receptors, Antigen, T-Cell; Receptors, Interleukin-7; Ursodeoxycholic Acid	2018
Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation. Digestive diseases and sciences, 2018, Volume: 63, Issue:2 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Drug Administration Schedule; Female; Humans; Jaundice; Middle Aged; Ursodeoxycholic Acid	2018
Editorial: Itching to Know: Role of Fibrates in PBC. The American journal of gastroenterology, 2018, Volume: 113, Issue:1 Topics: Bezafibrate; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2018
[Research advances in primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Nov-20, Volume: 25, Issue:11 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria; Ursodeoxycholic Acid	2017
[Advances in the treatment of primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Nov-20, Volume: 25, Issue:11 Topics: Autoimmune Diseases; Bile Ducts, Intrahepatic; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut, 2018, Volume: 67, Issue:9 Topics: Alanine Transaminase; Alkaline Phosphatase; Autoantibodies; Bilirubin; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Gastroenterology; Humans; Liver Cirrhosis, Biliary; Mitochondria; Predictive Value of Tests; Risk Assessment; Risk Factors; Sensitivity and Specificity; Societies, Medical; Treatment Outcome; United Kingdom; Ursodeoxycholic Acid	2018
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. PloS one, 2018, Volume: 13, Issue:4 Topics: Aged; Antidepressive Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cohort Studies; Databases, Factual; Depression; Disease-Free Survival; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Mianserin; Middle Aged; Mirtazapine; Proportional Hazards Models; Treatment Outcome; Ursodeoxycholic Acid	2018
Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA. Revista espanola de enfermedades digestivas, 2018, Volume: 110, Issue:9 Topics: Adult; Aged; Cholagogues and Choleretics; Cholangitis; Cohort Studies; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2018
[In process]. Medizinische Monatsschrift fur Pharmazeuten, 2017, Volume: 40, Issue:3 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Humans; Ursodeoxycholic Acid	2017
Ensuring timely treatment of patients with primary biliary cholangitis. The lancet. Gastroenterology & hepatology, 2018, Volume: 3, Issue:9 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Diagnosis of primary biliary cholangitis in a "teen" male patient. Clinics and research in hepatology and gastroenterology, 2019, Volume: 43, Issue:2 Topics: Age Factors; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Humans; Liver Diseases; Male; Thyroiditis, Autoimmune; Ursodeoxycholic Acid; Young Adult	2019
[Primary biliary cholangitis : an update]. Revue medicale suisse, 2018, Aug-29, Volume: 14, Issue:616 Topics: Autoimmune Diseases; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2018
Bezafibrate in Primary Biliary Cholangitis. The New England journal of medicine, 2018, 09-06, Volume: 379, Issue:10 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response. Annals of internal medicine, 2018, 10-16, Volume: 169, Issue:8 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
[Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial]. Der Internist, 2018, Volume: 59, Issue:12 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis. Gut and liver, 2018, 11-15, Volume: 12, Issue:6 Topics: Cholangitis; Humans; Lymphocytes; Neutrophils; Prognosis; Ursodeoxycholic Acid	2018
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:7 Topics: Cholagogues and Choleretics; Cholangitis; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prevalence; Prognosis; Pruritus; Retrospective Studies; Risk Assessment; Severity of Illness Index; Surveys and Questionnaires; United Kingdom; Ursodeoxycholic Acid	2019
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:2 Topics: Bezafibrate; Cholangitis; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:10 Topics: Adult; Age Factors; Aged; Cholagogues and Choleretics; Cholangitis; Female; Humans; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Treatment Outcome; Ursodeoxycholic Acid	2019
[Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019, Jan-20, Volume: 27, Issue:1 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid	2019
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis. Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Bezafibrate; Cholangitis; Female; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Journal of hepatology, 2019, Volume: 71, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Cholangitis; Disease Progression; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Risk; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2019
Biliary features in liver histology of children with autoimmune liver disease. Hepatology international, 2019, Volume: 13, Issue:4 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lymphocytes; Male; Prednisone; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2019
Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 2019, Volume: 115 Topics: Adenocarcinoma of Lung; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholagogues and Choleretics; Cholangitis; Humans; Lung Neoplasms; Male; Middle Aged; Nivolumab; Treatment Outcome; Ursodeoxycholic Acid	2019
Clinicopathological significance of serum fractalkine in primary biliary cirrhosis. Digestive diseases and sciences, 2013, Volume: 58, Issue:10 Topics: Biomarkers; Chemokine CX3CL1; Cholagogues and Choleretics; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2013
A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis. Journal of feline medicine and surgery, 2014, Volume: 16, Issue:10 Topics: Animals; Biopsy; Cat Diseases; Cats; Cell Proliferation; Cholangitis; Female; Immunohistochemistry; Liver; Lymphocytes; Male; Prednisolone; Ursodeoxycholic Acid	2014
Acute lymphocytic cholangitis and liver failure in an Amur tiger (Panthera tigris altaica). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2014, Volume: 45, Issue:1 Topics: Animals; Animals, Zoo; Anti-Infective Agents; Cholagogues and Choleretics; Cholangitis; Glucocorticoids; Liver Failure; Male; Metronidazole; Prednisolone; Tigers; Ursodeoxycholic Acid	2014
Recurrent common bile duct stones composed of ursodeoxycholic acid: a report of four cases. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:21 Topics: Aged; Cholagogues and Choleretics; Cholangitis; Choledocholithiasis; Female; Gallstones; Humans; Male; Middle Aged; Recurrence; Ursodeoxycholic Acid	2014
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology (Baltimore, Md.), 2016, Volume: 63, Issue:3 Topics: Algorithms; Cholangitis; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Ursodeoxycholic Acid	2016
[New therapeutic approaches are in the clinical trial]. Medizinische Monatsschrift fur Pharmazeuten, 2015, Volume: 38, Issue:2 Topics: Cholangitis; Clinical Trials as Topic; Humans; Isomerism; Ursodeoxycholic Acid	2015
Predicting risk in primary biliary cholangitis. Hepatology (Baltimore, Md.), 2016, Volume: 63, Issue:3 Topics: Cholangitis; End Stage Liver Disease; Female; Humans; Male; Ursodeoxycholic Acid	2016
Clonal Characteristics of Circulating B Lymphocyte Repertoire in Primary Biliary Cholangitis. Journal of immunology (Baltimore, Md. : 1950), 2016, 09-01, Volume: 197, Issue:5 Topics: Adult; Aged; Autoimmune Diseases; B-Lymphocytes; Cholangitis; Clone Cells; Female; Genetic Variation; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Mutation; Ursodeoxycholic Acid	2016
Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter. Clinical journal of gastroenterology, 2016, Volume: 9, Issue:5 Topics: Aged; Biopsy; Cholagogues and Choleretics; Cholangitis; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver; Middle Aged; Prednisolone; Ursodeoxycholic Acid	2016
Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis. Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:3 Topics: ADP-ribosyl Cyclase 1; B-Cell Activating Factor; Biomarkers; Cholangitis; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Mitochondria; Treatment Outcome; Ursodeoxycholic Acid	2017
Primary biliary cholangitis, let's try to keep the new nomenclature correct! The Netherlands journal of medicine, 2016, Volume: 74, Issue:6 Topics: Cholagogues and Choleretics; Cholangitis; Early Diagnosis; Humans; Liver Cirrhosis, Biliary; Prognosis; Terminology as Topic; Ursodeoxycholic Acid	2016
Obeticholic acid in primary biliary cholangitis. Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1 Topics: Chenodeoxycholic Acid; Cholangitis; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut, 2018, Volume: 67, Issue:3 Topics: Adult; Aged; Antibodies; Bacteria; Biomarkers; Case-Control Studies; Cholagogues and Choleretics; Cholangitis; Cross-Sectional Studies; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Nuclear Pore Complex Proteins; Prospective Studies; Ursodeoxycholic Acid; Young Adult	2018
Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient. World journal of gastroenterology, 2008, Sep-07, Volume: 14, Issue:33 Topics: Aged; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholecystectomy; Cholecystitis; Cholestasis, Intrahepatic; Combined Modality Therapy; Humans; Male; Treatment Outcome; Ursodeoxycholic Acid	2008
[Incidentally diagnosed stones of the gallbladder]. MMW Fortschritte der Medizin, 2008, Oct-23, Volume: 150, Issue:43 Topics: Adult; Aged; Cholangitis; Cholecystectomy; Cholecystitis; Cross-Sectional Studies; Diagnosis, Differential; Female; Gallstones; Humans; Incidental Findings; Male; Middle Aged; Prognosis; Ultrasonography; Ursodeoxycholic Acid	2008
[Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case]. Dakar medical, 2008, Volume: 53, Issue:2 Topics: Alkaline Phosphatase; Autoimmune Diseases; Bilirubin; Cholagogues and Choleretics; Cholangitis; Humans; Male; Middle Aged; Ursodeoxycholic Acid	2008
Atorvastatin-induced prolonged cholestasis with bile duct damage. Clinical drug investigation, 2010, Volume: 30, Issue:3 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Dyslipidemias; Heptanoic Acids; Humans; Male; Pyrroles; Ursodeoxycholic Acid	2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:5 Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; Chromatography, Gas; Hepatoblastoma; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Rats; Rats, Sprague-Dawley; Taurine; Taurolithocholic Acid; Ursodeoxycholic Acid	2010
A case of recovery from canine destructive cholangitis in a Miniature Dachshund. The Journal of veterinary medical science, 2011, Volume: 73, Issue:7 Topics: Animals; Anti-Bacterial Agents; Biopsy; Cholangitis; Dog Diseases; Dogs; Histocytochemistry; Male; Placental Extracts; Prednisolone; Ultrasonography; Ursodeoxycholic Acid	2011
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology, 2011, Volume: 141, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; HEK293 Cells; Humans; Immunity, Innate; Inflammation Mediators; Keratin-19; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Neomycin; NF-kappa B; Phosphorylation; Polymyxin B; src-Family Kinases; Time Factors; Toll-Like Receptor 4; Transfection; Ursodeoxycholic Acid	2011
Percutaneous management of bile-plug syndrome: a case report. Journal of pediatric surgery, 2011, Volume: 46, Issue:12 Topics: Bile; Catheterization; Cefotaxime; Cholangiography; Cholangitis; Cholecystostomy; Combined Modality Therapy; Common Bile Duct Diseases; Cytomegalovirus Infections; Drainage; Fibrosis; Fluoroscopy; Ganciclovir; Hepatitis, Viral, Human; Hepatomegaly; Humans; Infant; Jaundice, Obstructive; Male; Radiography, Interventional; Ultrasonography; Ursodeoxycholic Acid	2011
Retrospective comparison of prednisolone and ursodeoxycholic acid for the treatment of feline lymphocytic cholangitis. Veterinary journal (London, England : 1997), 2013, Volume: 195, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Cat Diseases; Cats; Cholagogues and Choleretics; Cholangitis; Drug Therapy, Combination; Male; Prednisolone; Retrospective Studies; Ursodeoxycholic Acid	2013
[Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis]. Deutsche medizinische Wochenschrift (1946), 2004, Nov-05, Volume: 129, Issue:45 Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy; Cholagogues and Choleretics; Cholangitis; Female; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Kidney; Leg Ulcer; Liver; Liver Cirrhosis, Biliary; Middle Aged; Thyroiditis, Autoimmune; Treatment Outcome; Ursodeoxycholic Acid	2004
Autoimmune cholangitis presented as fever of unknown origin. Chemotherapy, 2006, Volume: 52, Issue:6 Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Autoimmune Diseases; Biomarkers; Cholagogues and Choleretics; Cholangitis; Female; Fever of Unknown Origin; gamma-Glutamyltransferase; Humans; Methylprednisolone; Middle Aged; Ursodeoxycholic Acid	2006
[What should be done in case of asymptomatic biliary calculus?]. Revue medicale de la Suisse romande, 1984, Volume: 104, Issue:3 Topics: Age Factors; Cholangitis; Cholelithiasis; Deoxycholic Acid; Humans; Ursodeoxycholic Acid	1984
[Clinical and internal medicine therapy of biliary tract diseases]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1980, Aug-15, Volume: 35, Issue:16 Topics: Ampulla of Vater; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholangitis; Cholecystitis; Cholelithiasis; Diagnosis, Differential; Humans; Ursodeoxycholic Acid	1980
Surgical treatment of symptomatic biliary stones in patients with cystic fibrosis. The American surgeon, 1995, Volume: 61, Issue:9 Topics: Adolescent; Adult; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholecystectomy; Cholecystitis; Cholelithiasis; Cystic Fibrosis; Female; Gallstones; Humans; Male; Ursodeoxycholic Acid	1995
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology, 1996, Volume: 111, Issue:1 Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile; Chemical and Drug Induced Liver Injury; Cholangitis; Cholic Acids; Drug Resistance, Multiple; Food, Formulated; Gene Expression; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Mice; Mice, Mutant Strains; Ursodeoxycholic Acid	1996
Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver, 1996, Volume: 16, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoimmunity; Bilirubin; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Giant Cells; Hepatitis; Histocytochemistry; HLA Antigens; Humans; Immunosuppressive Agents; Male; Serology; Ursodeoxycholic Acid	1996
Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? Journal of clinical gastroenterology, 1996, Volume: 23, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Azathioprine; Cholangitis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Prednisone; Ursodeoxycholic Acid	1996
Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology, 1996, Volume: 28, Issue:3 Topics: Antibodies, Antinuclear; Autoimmune Diseases; Cholangitis; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Gastrointestinal Agents; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Middle Aged; Pyruvate Dehydrogenase Complex; Syndrome; Ursodeoxycholic Acid	1996
Clonal accumulation of V beta 5.1-positive cells in the liver of a patient with autoimmune cholangiopathy. Liver, 1997, Volume: 17, Issue:1 Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Cholangitis; Female; Hepatitis; Humans; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Liver; Liver Cirrhosis, Biliary; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Ursodeoxycholic Acid	1997
[Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?]. Gastroenterologia y hepatologia, 1997, Volume: 20, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Prednisone; Retrospective Studies; Ursodeoxycholic Acid	1997
[Unusual diagnosis in recurrent arthritis, erythema nodosum and arrhythmia]. Deutsche medizinische Wochenschrift (1946), 1997, Dec-05, Volume: 122, Issue:49 Topics: Adult; Arrhythmias, Cardiac; Arthritis; Biopsy; Cholangitis; Chronic Disease; Diagnosis, Differential; Erythema Nodosum; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Recurrence; Time Factors; Tomography, X-Ray Computed; Ursodeoxycholic Acid	1997
The role of therapeutic endoscopy associated with extracorporeal shock-wave lithotripsy and bile acid treatment in the management of Caroli's disease. Endoscopy, 1998, Volume: 30, Issue:6 Topics: Caroli Disease; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Combined Modality Therapy; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Lithotripsy; Male; Middle Aged; Sphincterotomy, Endoscopic; Time Factors; Ursodeoxycholic Acid	1998
The role of therapeutic endoscopy associated with extracorporeal shock-wave lithotripsy and bile acid treatment in the management of Caroli's disease. Endoscopy, 1999, Volume: 31, Issue:3 Topics: Caroli Disease; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Gastrointestinal Agents; Humans; Lithotripsy; Ursodeoxycholic Acid	1999
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:1 Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Cholagogues and Choleretics; Cholangitis; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Transaminases; Ursodeoxycholic Acid	2000
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; HLA Antigens; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	2000
[Chronic hepatitis and cholangitis. The liver at risk]. MMW Fortschritte der Medizin, 1999, Jun-24, Volume: 141, Issue:25 Topics: Antiviral Agents; Cholangitis; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Ursodeoxycholic Acid	1999
Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography. Endoscopy, 2001, Volume: 33, Issue:7 Topics: Acute Disease; Aged; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholangitis, Sclerosing; Dilatation, Pathologic; Disease Progression; Humans; Male; Ursodeoxycholic Acid	2001
Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Digestive diseases and sciences, 2002, Volume: 47, Issue:6 Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; Hepatitis C, Chronic; Humans; Liver; Middle Aged; Mitochondria, Liver; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes. Prescrire international, 2002, Volume: 11, Issue:59 Topics: Cholagogues and Choleretics; Cholangitis; Follow-Up Studies; France; Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2002
[Choice and modalities of the treatment of biliary lithiasis]. Schweizerische medizinische Wochenschrift, 1986, Aug-05, Volume: 116, Issue:31-32 Topics: Age Factors; Aged; Chenodeoxycholic Acid; Cholangitis; Cholecystectomy; Cholelithiasis; Endoscopy; Female; Humans; Male; Middle Aged; Pancreatitis; Risk; Ursodeoxycholic Acid	1986